Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts

International Journal of Cancer

Volumn 129, Issue 2, 2011, Pages 319-330

  Brune, Jan C ^a   Tormin, Ariane ^a   Maria C Johansson, ^b   Rissler, Pehr ^b   Brosjö, Otte ^c   Löfvenberg, Richard ^d   Von Steyern, Fredrik Vult ^b   Mertens, Fredrik ^b   Rydholm, Anders ^b   Scheding, Stefan ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer associated fibroblasts; Mesenchymal stromal cells; Osteogenic sarcoma; Osteosarcoma; Tumor stroma

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA SMOOTH MUSCLE ACTIN; ENDOGLIN; HERMES ANTIGEN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; THY 1 ANTIGEN; VIMENTIN;

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL STRUCTURE; COLONY FORMATION; COLONY FORMING UNIT F; CONTROLLED STUDY; CULTURE TECHNIQUE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ADOLESCENT; ADULT; BONE MARROW CELL; BONE TUMOR; CHILD; CYTOLOGY; FEMALE; MALE; MIDDLE AGED; MULTIPOTENT STEM CELL; PATHOLOGY; STROMA CELL;

ADOLESCENT; BONE MARROW CELLS; BONE NEOPLASMS; CELL CULTURE TECHNIQUES; CHILD; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MULTIPOTENT STEM CELLS; OSTEOSARCOMA; STROMAL CELLS; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 79961123373     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25697     Document Type: Article

References (42)

1. Marx J. Cancer biology. All in the stroma: Cancer's Cosa Nostra. Science 2008;320: 38-41. (Pubitemid 351490738)
2. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-9.
3. Fierro FA, Sierralta WD, Epuñan MJ, Minguell JJ. Marrow-derived mesenchymal stem cells: Role in epithelial tumor cell determination. Clin Exp Metastasis 2004; 21:313-9. (Pubitemid 39434541)
4. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/ CXCL12 secretion. Cell 2005;121: 335-48. (Pubitemid 40692295)
5. Misra S, Ghatak S, Toole BP. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 2005;280:20310-5. (Pubitemid 40776728)
6. Toole BP. Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer 2004;4:528-39. (Pubitemid 38868622)
7. Weaver VM, Leliévre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002;2:205-16. (Pubitemid 41043976)
8. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002;16:1713-24.
9. Troyer DL, Weiss ML. Concise review: Wharton's Jelly-derived cells are a primitive stromal cell population. Stem Cells 2007;26: 591-9.
10. Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, Neumann U, Scheding S. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 2004;78:925-9. (Pubitemid 39298539)
11. Castro-Malaspina H, Ebell W, Wang S. Human bone marrow fibroblast colonyforming units (CFU-F). Prog Clin Biol Res 1984;154:209-36.
12. Kocaoemer A, Kern S, Klüter H, Bieback K. Human AB serum and thrombinactivated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007;25:1270-8. (Pubitemid 46684887)
13. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64:278-94. (Pubitemid 27065442)
14. Caplan AI. Review: Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics. Tissue Eng 2005;11: 1198-211. (Pubitemid 41321423)
15. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M. Mesenchymal stem cells: Potential precursors for tumor stroma and targeteddelivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-603. (Pubitemid 39534883)
16. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004; 64:8492-5. (Pubitemid 39552057)
17. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D. Carcinomaassociated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008;68:4331-9.
18. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000;103: 481-90.
19. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-63. (Pubitemid 47525152)
20. Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N, Stamp G, Bonnet D, Janes SM. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007;25:1586-94. (Pubitemid 47106029)
21. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007;25:371-9. (Pubitemid 46232791)
22. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN, Steindler DA. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 2005;7:967-76.
23. Tormin A, Brune JC, Olsson E, Valcich J, Neuman U, Olofsson T, Jacobsen SE, Scheding S. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy 2009;11:114-28.
24. Mandahl. Methods in solid tumor cytogenetics. In: Rooney DE, ed. Human cytogenetics: Malignancy and acquired abnormalities. New York: Oxford University Press, 2001. 165-203.
25. Shaffer LG, Slovak ML, Campbell LJ, eds. ISCN (2009): An International system for human cytogenetic nomenclature. Brussels: S. Karger, 2009.
26. Thornthwaite JT, Sugarbaker EV, Temple WJ. Preparation of tissues for DNA flow cytometric analysis. Cytometry 1980;1: 229-37. (Pubitemid 11088865)
27. Gisselsson D, Pålsson E, Höglund M, Domanski H, Mertens F, Pandis N, Sciot R, Dal Cin P, Bridge JA, Mandahl N. Differentially amplified chromosome 12 sequences in low-and high-grade osteosarcoma. Genes Chromosomes Cancer 2002;33:133-40. (Pubitemid 34052494)
28. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93. (Pubitemid 36181903)
29. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C. BioArray Software Environment (BASE): A platform for comprehensive management and analysis of microarray data. Genome Biol 2002;3:SOFTWARE0003.1-6.
30. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 2003; 34:374-8. (Pubitemid 36184095)
31. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J. TM4 microarray software suite. Methods Enzymol 2006;411:134-93.
32. Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, Bornhäuser M. Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 2007;40: 355-66. (Pubitemid 46802187)
33. Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, Gruia AT, Tanasie G, Bunu C, Crisnic D, Gherghiceanu M, Tatu FR, Tatu CS, et al. Tumor-associated fibroblasts and mesenchymal stem cells: More similarities than differences. J Cell Mol Med, in press.
34. Lin TM, Chang HW, Wang KH, Kao AP, Chang CC, Wen CH, Lai CS, Lin SD. Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun 2007;361:883-9.
35. Cao H, Xu W, Qian H, Zhu W, Yan Y, Zhou H, Zhang X, Xu X, Li J, Chen Z. Mesenchymal stem cell-like cells derived from human gastric cancer tissues. Cancer Lett 2008;274:61-71.
36. Dudley AC, Shih SC, Cliffe AR, Hida K, Klagsbrun M. Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine. Br J Cancer 2008;99:118-25. (Pubitemid 351920247)
37. Tataria M, Quarto N, Longaker MT, Sylvester KG. Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells. J Pediatr Surg 2006;41:624-32.
38. Desmouliére A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factorbeta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-11. (Pubitemid 23188802)
39. Rønnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995;95: 859-73.
40. Shor AC, Agresta SV, D'Amato GZ, Sondak VK. Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas. Cancer Control 2008;15:47-54. (Pubitemid 351481991)
41. Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PC. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study. Pediatr Blood Cancer 2008; 50:254-8.
42. Weisberg E, Manley PW, Breitenstein W, Brüggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 2005;7:129-41. (Pubitemid 40248339)